G. Cieslinski et al., RISK OF ENDOMYOCARDIAL BIOPSY IN IMMUNOSUPPRESSED PATIENTS AFTER CARDIAC TRANSPLANTATION, La Presse medicale, 23(20), 1994, pp. 937-939
Objectives: Central venous puncture is required for endomyocardial bio
psy to identify rejection after cardiac transplantation. We evaluated
our use of the Seldinger technique to determine the safety of this inv
asive method. Methods: In 42 immunosuppressed patients central venous
puncture was performed after cardiac transplantation using the Selding
er technique for right heart biopsy. Together with physical examinatio
ns, chest X-ray and cardiac ultrasonography were performed during the
inhospital follow-up. Outpatient follow-up continues and all reported
adverse effects were evaluated by the attending cardiologist. Results:
There were a total of 620 central venous punctures, most via the righ
t internal jugular vein (77.9%). The planned puncture could not be per
formed in 3.2% of the cases and an alternative site was used. The femo
ral approach was associated with the longest radiation time. No severe
adverse effects were observed and no complications (infection, large
haematoma, pneumothorax, severe rhythm disorders) were recorded. Concl
usion: Even in immunosuppressed patients frequently requiring central
venous puncture, right heart endomyocardial biopsy can be safetly perf
ormed to evaluate rejection.